ISSN 2326-7291
International Journal of Public Health and Epidemiology ISSN 2326-7291 Vol. 5 (2), pp. 244-245, February, 2016. © International Scholars Journals
Case Report
Management of severe and refractory HLA-B27 negative heel enthesitis using adalimumab
Faisal Salman
Department of Rheumatology, King AbdulAziz University Hospital, Jeddah, Saudi Arabia.
*Corresponding author. E-mail: [email protected]
Accepted 15 November, 2015
Abstract
Enthesitis is a common manifestation of HLA-B27 positive spondyloarthritis. Here, we report the successful use of adalimumab for the treatment of an unusual case of isolated heel enthesitis, in an HLA-B27 negative patient without additional clinical symptoms of undifferentiated spondyloarthritis. These findings contribute to the growing body of evidence that supports the beneficial use of anti-tumor necrosis factor-alpha therapies for patients with enthesitis.
Key words: Adalimumab, enthesitis, spondyloarthritis, magnetic resonance imaging.